These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20717844)

  • 1. Abstracts of the European Society of Clinical Pharmacy International Workshop on Patient Safety and Pharmacy. May 10-11, 2010. Uppsala, Sweden.
    Pharm World Sci; 2010 Oct; 32(5):670-89. PubMed ID: 20717844
    [No Abstract]   [Full Text] [Related]  

  • 2. An approach to clinical pharmacy.
    McCarron MM
    Drug Intell Clin Pharm; 1975 Jan; 9(1):12-6. PubMed ID: 10236921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of Pharmacy in the Promotion of Drug Safety in Pharmacotherapy].
    Satoh M
    Yakugaku Zasshi; 2018; 138(2):149-150. PubMed ID: 29386428
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring the potential impact of hospital ward-based pharmacy interns on drug safety.
    Schorr SG; Eickhoff C; Feldt S; Hohmann C; Schulz M
    Pharmazie; 2014 Apr; 69(4):316-20. PubMed ID: 24791599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems.
    Modig S; Holmdahl L; Bondesson Å
    Int J Clin Pharm; 2016 Feb; 38(1):41-5. PubMed ID: 26582483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.
    Dhanani TC; Mantovani EH; Turner JR
    Int J Pharm Pract; 2017 Apr; 25(2):176-179. PubMed ID: 27677250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units.
    Okumura LM; Silva DM; Comarella L
    Rev Paul Pediatr; 2016 Dec; 34(4):397-402. PubMed ID: 27578187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.S. pharmacy policy: a public health perspective on safety and cost.
    Rosenau PV; Lal LS; Glasser JH
    Soc Work Public Health; 2009; 24(6):543-67. PubMed ID: 19821192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost benefits of clinical pharmacy.
    Stuart DM
    Drug Intell Clin Pharm; 1976 Mar; 10(3):181-2. PubMed ID: 10304761
    [No Abstract]   [Full Text] [Related]  

  • 12. 3rd European Workshop on Drug Information, Risk Assessment and Risk Communication. Helsinki, Finland, 14-16 June 1995. Abstracts.
    Pharm World Sci; 1995 May; 17(3 Suppl E):E3-17. PubMed ID: 7606226
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug reactions. A problem for drug regulatory agencies.
    Westerholm B
    Int J Clin Pharmacol; 1973 Apr; 7(2):183-9. PubMed ID: 4731286
    [No Abstract]   [Full Text] [Related]  

  • 14. Abstracts of the European Society of Clinical Pharmacy International Workshop on Malabsorption and Malnutrition, A Challenge for Clinical Pharmacists, 26-27 April 2021.
    Int J Clin Pharm; 2021 Jun; 43(3):800-815. PubMed ID: 34121154
    [No Abstract]   [Full Text] [Related]  

  • 15. Abstracts of the European society of clinical pharmacy : International workshop on taking care of patients with neurological disorders, 28-29 April 2022.
    Int J Clin Pharm; 2022 May; 44(3):816-831. PubMed ID: 35608745
    [No Abstract]   [Full Text] [Related]  

  • 16. [STABILITY OF DRUGS. II. SIMULTANEOUS REACTIONS].
    PHOHORSKY J; VACHEK J; KONECNY J
    Cesk Farm; 1963 Dec; 12():532-6. PubMed ID: 14118732
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacy service practice in a Chinese tertiary hospital.
    Chen B; Huang JJ; Chen HF; Xu BM
    Drug Metab Pers Ther; 2015 Dec; 30(4):215-30. PubMed ID: 26457791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmaceutical incompatibilities. Theoretical and practical principles].
    IONESCU-STOIAN P; STANCIU N
    Pharmazie; 1960 Feb; 15():25-6. PubMed ID: 13852935
    [No Abstract]   [Full Text] [Related]  

  • 19. The development and piloting of "ATTEND DR," a clinical teaching tool to identify and prioritize potential causes of adverse drug reactions.
    King M; Khan S
    Curr Pharm Teach Learn; 2017; 9(1):66-71. PubMed ID: 29180157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance--Current and Future Challenges. Abstracts of the International Society of Pharmacovigilance annual conference. Dublin, Ireland, 6-8 October 2004.
    Drug Saf; 2004; 27(12):911-77. PubMed ID: 15988859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.